KORU Medical Systems Reports Q2 2026 Results, Updates Guidance

What Happened

• KORU Medical Systems, Inc. (KRMD) filed a Form 8‑K on August 5, 2026 to announce its financial results for the second fiscal quarter ended June 30, 2026 and to update financial guidance for the fiscal year ended December 31, 2025. The company issued a press release (furnished as Exhibit 99.1) and scheduled a related conference call for August 5, 2026 at 4:30 p.m. Eastern Time.
• The company disclosed and reconciled non‑GAAP measures in the press release and call — specifically "adjusted EBITDA" and "adjusted diluted EPS" — and provided definitions and a GAAP-to-non‑GAAP reconciliation in Exhibit 99.1.

Key Details

• Press release date and 8‑K filing: August 5, 2026; quarter covered: quarter ended June 30, 2026.
• Updated financial guidance pertains to the fiscal year ended December 31, 2025 (as disclosed in the filing).
• Conference call: August 5, 2026 at 4:30 p.m. Eastern Time.
• Non‑GAAP metrics disclosed: adjusted EBITDA and adjusted diluted EPS (definitions and reconciliation included in Exhibit 99.1).

Why It Matters

• The filing provides the company’s latest quarterly performance and an update to prior fiscal‑year guidance, which are material inputs for evaluating near‑term outlook and valuation.
• Management’s use of adjusted EBITDA and adjusted diluted EPS gives investors an additional view of operating performance and comparability, but the company cautions these are supplemental to — not replacements for — GAAP results; the reconciliation is included for review.
• Retail investors should review the press release and the company’s full financial statements and listen to the conference call for management commentary and any further details.